Predicted quality benefits of achievable performance benchmarks of chronic heart failure care in China: results from a nationwide observational study.
cross_sectional · Level IV
Where this comes from
- Record sourced from PubMed, PMID 32967875.
- Also identified by DOI 10.1136/bmjopen-2020-036786 and PMC identifier 7513604.
- Licence recorded as CC BY-NC.
- Because redistribution is not established, this page shows the abstract only. Follow the links below for the full text.
Abstract
This study aimed to set a data-driven achievable performance benchmark, explore the process-outcome association and speculate about the net gain in quality improvement with benchmarking. Observational study. Patient survey conducted at 466 secondary and tertiary hospitals across 31 provinces, autonomous regions and municipalities in China. 183 334 patients diagnosed with chronic heart failure (CHF) who were treated at 466 Chinese hospitals from January 2011 through May 2017. Hospital process composite performance (HPCP). Patient-level and hospital-level characteristics. Patients getting better or recovered after treatment, in-hospital mortality, length of hospital stay (LOS) and medical cost. HPCP was calculated using denominator-based weights. Mixed random-intercept models were used to evaluate the contributions of HPCP on patient outcomes and to speculate quality improvement after adjusting HPCP to benchmark level. When all hospitals were to operate at the benchmark level, the proportion of patients getting better or recovered after treatment would increase in most hospitals, particularly those with low baseline rates. However, there was no evidence for lowering in-hospital mortality, significant savings in cost or shortening LOS. Increasing the adherence rate of CHF care and closing the gap in HPCP between hospitals have important implications for improving patient condition.
Medical subject headings
- Benchmarking
- Heart Failure